President Trump Delivers on Promise to Cut Prescription Drug Prices with Bold Action Targeting Big Pharma and Global Exploitation
In a landmark move to lower the cost of prescription drugs and end global freeloading on American innovation, President Donald Trump has signed a sweeping new Executive Order aimed at delivering historic price relief for American patients and taxpayers.
“No more Americans paying five times more for the same pill,” Trump declared during a press briefing in the Oval Office, surrounded by administration officials and healthcare advisors.
The new order mandates aggressive reforms across the pharmaceutical supply chain by:
-
Directing the U.S. Trade Representative and Secretary of Commerce to ensure that foreign countries are no longer allowed to exploit U.S. consumers by undercutting market prices.
-
Establishing “Most-Favored-Nation” pricing to ensure that Americans pay no more than the lowest price charged in other developed countries.
-
Cutting out middlemen by enabling Americans to purchase directly from manufacturers.
-
Threatening strong regulatory action if drug makers refuse to comply, including imposing binding price caps and breaking up anti-competitive practices.
A Massive Taxpayer Win
Right now, Americans pay over three times more for name-brand drugs than their counterparts in other wealthy nations—even after discounts. Despite representing less than 5% of the global population, the U.S. funds a staggering 75% of global pharmaceutical profits.
That means American families and seniors are effectively subsidizing socialized medicine in foreign countries while getting gouged at the pharmacy. Trump’s executive order flips that equation on its head.
“No longer will Americans bankroll socialist healthcare abroad. We will no longer tolerate middlemen and bureaucrats protecting foreign interests over our own people,” Trump said.
Fulfilling a First-Term Promise
This bold action builds on Trump’s first-term agenda to make prescription drug prices radically transparent and competitive. Among those efforts:
-
Medicare beneficiaries protected from overpaying for drugs other countries receive at steep discounts.
-
Expanded access to generics and biosimilars to drive down prices.
-
Facilitated drug importation from Canada and other approved nations.
Those reforms were killed by the Biden administration. Now, Trump is reviving and expanding them.
“The Biden White House negotiated prices 78% higher than our peer nations. That’s not putting America first—that’s betraying the American people,” the president noted.
Putting Americans and Patients First
The new order also includes Medicaid in its reforms—an expansion from the original Medicare-only scope. It ensures that low-income families, seniors, and working-class Americans benefit directly from the administration’s crackdown on globalist pricing scams and pharmaceutical greed.
“Americans have been paying the highest drug prices in the world for far too long,” said the White House in its official fact sheet. “This executive order reverses the flow of money—away from waste, corruption, and socialism, and back into the pockets of American families.”
A New Era of Drug Price Justice
With this Executive Order, Trump sends a clear message to Big Pharma and